Heyuan Biotechnology Co., Ltd. has been registered for listing counseling. It plans to do an A-share IPO. The consulting agency is CITIC Construction Investment. The company is engaged in the development of CAR-T cell therapeutics.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.